Ingredients Revenue Growth and New Product Momentum
Ingredients operations revenue increased to $265.2M for the nine months (vs $249.0M prior year), a +6.5% year-over-year improvement. Management stated sales of new/value-added products are meaningful and that ingredients sales are up ~7% year-to-date vs. prior year, reflecting progress converting product development and commercial investments into revenue.
Refinancing and Liquidity Expansion
Company refinanced and upsized its senior unsecured credit facility by $250M, lowering borrowing cost and expanding financial flexibility. Reported liquidity availability (cash + committed/uncommitted lines) totaled $917M as of December 31, 2025.
Tobacco Segment Resilience
Despite comparisons to an extraordinary prior-year quarter, tobacco remains a strong performer: nine-month tobacco revenue $1.94B (vs $2.00B prior, -3.0%) and segment operating income $185.0M (vs $194.4M prior, -4.8%). Management highlighted that current year-to-date and quarter results are among the highest in the last four years and cited continued firm customer demand and expanded third-party processing.
Strategic Investments and Facility Expansion
Universal Ingredients completed the Lancaster, PA facility expansion just over a year ago and has continued to invest in commercial sales, R&D, product development and production capabilities to support long-term growth and cross-selling opportunities across the platform.
Sustainability Progress
The company increased renewable electricity consumption nearly sixfold year-over-year and now sources approximately 17.7% of global electricity from renewable energy. Management reaffirmed science-based emissions targets and a net-zero by 2050 commitment.
Leadership Appointment
Announced appointment of a new CFO, Steven F. Deal, effective April 1, 2026, signaling strengthened financial leadership to support execution of strategic priorities.